| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $45.9M | — | +65.3% |
| SG&A Expense | $23.6M | — | +93.9% |
| Operating Income | -$69.5M | — | -74.0% |
| Pre-tax Income | -$63.5M | — | -86.8% |
| Income Tax | $51K | — | -57.1% |
| Net Income | -$63.5M | — | -86.3% |
| EPS (Basic) | -$1.65 | — | -61.8% |
| EPS (Diluted) | -$1.65 | — | -61.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $88.9M | -2.4% | -27.5% |
| Short-term Investments | $641.2M | -8.4% | +12.1% |
| Current Assets | $747.5M | -7.0% | +5.9% |
| Total Assets | $750.2M | -7.0% | +5.8% |
| Current Liabilities | $31.1M | -15.0% | +66.2% |
| Long-term Debt | $29.4M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$62.2M | — | -50.4% |
| Capital Expenditures | $0 | — | -100.0% |
| Investing Cash Flow | $58.3M | — | +121.4% |
| Financing Cash Flow | $1.7M | — | -99.3% |
| Free Cash Flow | -$62.2M | — | -47.4% |
| +2.9% |
| Total Liabilities | $61.8M | -7.9% | +26.3% |
| Stockholders' Equity | $688.4M | -6.9% | +4.3% |